首页 > 最新文献

European Journal of Cancer最新文献

英文 中文
A-168 International study of Sezary Syndrome reveals improved disease-specific survival from modern systemic therapies A-168 对塞扎里综合征的国际研究显示，现代系统疗法提高了疾病特异性生存率
IF 7.6 1区 医学 Q1 ONCOLOGY
European Journal of Cancer
Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114391
B.A. Campbell, G. Dobos, Z. Haider, M. Bagot, F. Evison, C. van der Weyden, C. McCormack, C. Ram-Wolff, M. Miladi, M. Prince, J. Scarisbrick
{"title":"A-168 International study of Sezary Syndrome reveals improved disease-specific survival from modern systemic therapies","authors":"B.A. Campbell, G. Dobos, Z. Haider, M. Bagot, F. Evison, C. van der Weyden, C. McCormack, C. Ram-Wolff, M. Miladi, M. Prince, J. Scarisbrick","doi":"10.1016/j.ejca.2024.114391","DOIUrl":"10.1016/j.ejca.2024.114391","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114391"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A-120 Radiotherapy of Cutaneous Lymphomas: Real-world Pattern-of-Care Analysis Among EORTC Members A-120 皮肤淋巴瘤的放射治疗：EORTC 成员的真实世界护理模式分析
IF 7.6 1区 医学 Q1 ONCOLOGY
European Journal of Cancer
Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114404
K. Elsayad, E. Guenova, B. Fournier, C. Fernandes, R. Cowan, D. Correia, Cutaneous Lymphoma Tumour Group
{"title":"A-120 Radiotherapy of Cutaneous Lymphomas: Real-world Pattern-of-Care Analysis Among EORTC Members","authors":"K. Elsayad, E. Guenova, B. Fournier, C. Fernandes, R. Cowan, D. Correia, Cutaneous Lymphoma Tumour Group","doi":"10.1016/j.ejca.2024.114404","DOIUrl":"10.1016/j.ejca.2024.114404","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114404"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A-154 Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management A-154 皮肤T细胞淋巴瘤治疗中可能出现的莫干单抗相关炎症性肠病
IF 7.6 1区 医学 Q1 ONCOLOGY
European Journal of Cancer
Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114401
G. Blanchard, M. Blanchard, P. Bernard, J. Doms, B. Cortés, S. Boulinguez, E. Guenova
{"title":"A-154 Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management","authors":"G. Blanchard, M. Blanchard, P. Bernard, J. Doms, B. Cortés, S. Boulinguez, E. Guenova","doi":"10.1016/j.ejca.2024.114401","DOIUrl":"10.1016/j.ejca.2024.114401","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114401"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A-162 Identifying Patients With Poor Outcomes in Mycosis Fungoides & Sezary syndrome For Improved Management Choices A-162 识别真菌病和塞扎里综合征疗效不佳的患者以改进治疗选择
IF 7.6 1区 医学 Q1 ONCOLOGY
European Journal of Cancer
Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114389
J. Scarisbrick, Y. Kim
{"title":"A-162 Identifying Patients With Poor Outcomes in Mycosis Fungoides & Sezary syndrome For Improved Management Choices","authors":"J. Scarisbrick, Y. Kim","doi":"10.1016/j.ejca.2024.114389","DOIUrl":"10.1016/j.ejca.2024.114389","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114389"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A-298 RESMAIN: Results of a multicenter, randomized, double blind, placebo-controlled trial to evaluate RESminostat for MAINtenance treatment in advanced stage Mycosis fungoides or Sézary syndrome A-298 RESMAIN：一项多中心、随机、双盲、安慰剂对照试验的结果，以评估 RESminostat 用于晚期真菌病或塞扎里综合征 MAIN 维护治疗的效果
IF 7.6 1区 医学 Q1 ONCOLOGY
European Journal of Cancer
Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114406
R. Stadler, S. Woei-A-Jin, R. Dummer, C. Mitteldorf, E. Papadavid, P. Quaglino, P. Ortiz, E. Guenova, R. Abe, A.M. Busschots, J. Scarisbrick
{"title":"A-298 RESMAIN: Results of a multicenter, randomized, double blind, placebo-controlled trial to evaluate RESminostat for MAINtenance treatment in advanced stage Mycosis fungoides or Sézary syndrome","authors":"R. Stadler, S. Woei-A-Jin, R. Dummer, C. Mitteldorf, E. Papadavid, P. Quaglino, P. Ortiz, E. Guenova, R. Abe, A.M. Busschots, J. Scarisbrick","doi":"10.1016/j.ejca.2024.114406","DOIUrl":"10.1016/j.ejca.2024.114406","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114406"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A-198 Real-world effectiveness of mogamulizumab in Spain and Portugal: Second interim analysis of the MIBERIC study A-198 莫干珠单抗在西班牙和葡萄牙的实际疗效：MIBERIC研究的第二次中期分析
IF 7.6 1区 医学 Q1 ONCOLOGY
European Journal of Cancer
Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114405
P.O. Romero, R.M. Pujol, M. Cravo, C.M. Montserrat, I.Q. Cuba, D.N. Rodríguez, P. Fernández-Caldas González, M.A. Cortés, A. Combalia, R.M. Rodríguez Núñez, R. Córdoba, R. Cabral, A. Núñez, I. Zeberio, R. Fernández-de-Misa, M.L. Velasco, E.M. Feijoo, X. Martín-Martitegui, F.J. Capote, J.F. Millán Cayetano, A.M. Villar
{"title":"A-198 Real-world effectiveness of mogamulizumab in Spain and Portugal: Second interim analysis of the MIBERIC study","authors":"P.O. Romero, R.M. Pujol, M. Cravo, C.M. Montserrat, I.Q. Cuba, D.N. Rodríguez, P. Fernández-Caldas González, M.A. Cortés, A. Combalia, R.M. Rodríguez Núñez, R. Córdoba, R. Cabral, A. Núñez, I. Zeberio, R. Fernández-de-Misa, M.L. Velasco, E.M. Feijoo, X. Martín-Martitegui, F.J. Capote, J.F. Millán Cayetano, A.M. Villar","doi":"10.1016/j.ejca.2024.114405","DOIUrl":"10.1016/j.ejca.2024.114405","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114405"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A-238 Increased mortality due to lymphoma and infections in patients with mycosis fungoides and Sézary syndrome: A Swedish nationwide, population-based cohort study A-238 真菌病和塞扎里综合征患者因淋巴瘤和感染导致的死亡率增加：一项瑞典全国性人群队列研究
IF 7.6 1区 医学 Q1 ONCOLOGY
European Journal of Cancer
Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114421
L.U. Ivert, S. Ekberg, K.E. Smedby, H. Brauner
{"title":"A-238 Increased mortality due to lymphoma and infections in patients with mycosis fungoides and Sézary syndrome: A Swedish nationwide, population-based cohort study","authors":"L.U. Ivert, S. Ekberg, K.E. Smedby, H. Brauner","doi":"10.1016/j.ejca.2024.114421","DOIUrl":"10.1016/j.ejca.2024.114421","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114421"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142417454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
32 (PB020): Discovery of novel MTA-cooperative PRMT5 inhibitors as targeted therapeutics for MTAP-deleted cancers 32 (PB020)：发现新型 MTA 协作 PRMT5 抑制剂，作为 MTAP 缺失型癌症的靶向治疗药物
IF 7.6 1区 医学 Q1 ONCOLOGY
European Journal of Cancer
Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114560
A. Radzimierski, A. Bobowska, A. Stachowicz, K. Kuś, K. Kozłowska-Tomczyk, A. Ludwig-Słomczyńska, A. Gołas, M. Żukowska, G. Ćwiertnia, K. Brzózka, M. Nowak, A. Bartosik, D. Pez
{"title":"32 (PB020): Discovery of novel MTA-cooperative PRMT5 inhibitors as targeted therapeutics for MTAP-deleted cancers","authors":"A. Radzimierski, A. Bobowska, A. Stachowicz, K. Kuś, K. Kozłowska-Tomczyk, A. Ludwig-Słomczyńska, A. Gołas, M. Żukowska, G. Ćwiertnia, K. Brzózka, M. Nowak, A. Bartosik, D. Pez","doi":"10.1016/j.ejca.2024.114560","DOIUrl":"10.1016/j.ejca.2024.114560","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114560"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
99 (PB087): Discovery and characterization of BRD4 degraders utilizing diverse E3 ligases for treatment of acute myeloid leukemia (AML). 99 (PB087)：利用多种 E3 连接酶发现和鉴定用于治疗急性髓性白血病 (AML) 的 BRD4 降解剂。
IF 7.6 1区 医学 Q1 ONCOLOGY
European Journal of Cancer
Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114623
M. Hamada, S. Ooike, K. Ohba, Y. Niwa, Y. Togashi, H. Maruyama, T. Matsudaira, T. Hosoi, M. Tokura, R. Fujita, M. Tanaka
{"title":"99 (PB087): Discovery and characterization of BRD4 degraders utilizing diverse E3 ligases for treatment of acute myeloid leukemia (AML).","authors":"M. Hamada, S. Ooike, K. Ohba, Y. Niwa, Y. Togashi, H. Maruyama, T. Matsudaira, T. Hosoi, M. Tokura, R. Fujita, M. Tanaka","doi":"10.1016/j.ejca.2024.114623","DOIUrl":"10.1016/j.ejca.2024.114623","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114623"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
41 (PB029): Preclinical characterization of ABSK131, a potential best-in-class MTAcooperative PRMT5 inhibitor 41（PB029）：潜在的同类最佳 MTA 合作 PRMT5 抑制剂 ABSK131 的临床前表征
IF 7.6 1区 医学 Q1 ONCOLOGY
European Journal of Cancer
Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114569
W. Pan, H. Wang, F. Qi, H. Deng, H. Yu, Y.C. Xu, Z. Chen, H. Ying
{"title":"41 (PB029): Preclinical characterization of ABSK131, a potential best-in-class MTAcooperative PRMT5 inhibitor","authors":"W. Pan, H. Wang, F. Qi, H. Deng, H. Yu, Y.C. Xu, Z. Chen, H. Ying","doi":"10.1016/j.ejca.2024.114569","DOIUrl":"10.1016/j.ejca.2024.114569","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114569"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
European Journal of Cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1